https://www.avient.com/sites/default/files/2024-11/Cesa_ WithStand_ Antimicrobial Additives-Medical Gown-Case study snapshot.pdf
Medical gown manufacturer
MEDICAL GOWN
MANUFACTURER
P P N O N W O V E N M U L T I L A Y E R S
• Excellent anti-microbial and anti-virus performance
• Pass JIS Test
• Provide technical support including specific specs,
processing and molding recommendations
• Customized anti-virus solutions designed to
support performance standards for materials
used in the surgical environment
• Provided technical support for material
selection, part & tool design, and process
development to accelerate commercialization
• Supported customer’s products pass the JIS
test
Cesa WithStand Antimicrobial Additives
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Hong Kong %28English%29.pdf
Seller has based any recommendations to Buyer upon information
that Seller considers reliable, but Seller makes no warranty as to any
results Buyer might obtain in Buyer’s use(s) for the Product.
Where the Products are delivered by partial shipments,
no default or failure by Seller in respect of any one or more Products
shall vitiate the contract or relevant purchase order(s) in respect of
the Products.
Unless Seller and Buyer have expressly agreed to a
firm delivery date term in a single writing signed by both parties,
delay in delivery of any Products shall not relieve Buyer of its
obligation to accept delivery thereof or entitle Buyer to refuse
performance of or repudiate the contract or relevant purchase
order(s).
https://www.avient.com/sites/default/files/2024-11/AVNT M11 Investor Presentation_w_Non-GAAP.pdf
Microsoft PowerPoint - AVNT M11 Investor Presentation
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
N OV E M B E R 2 0 2 4
DISCLAIMER
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Disruptions or inefficiencies in our supply chain, logistics, or operations;
• Changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Demand for our products and services;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
• Our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA;
• Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts and any recessionary conditions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2023 under Item 1A, “Risk Factors.”
EBITDA
$130 million
+6%
(+7% ex FX)Net Sales
$815 million
+8%
(+8.5% ex FX)
Net Sales
$815 million
+8%
(+8.5% ex FX)
Q 3 2024 R ES U LT S
TOTAL COMPANY
$754
$815
$123
$130
(in millions)
$0.57
(in millions)
Adjusted EBITDA Adjusted EPS
8
+ 8%
(+8.5% excluding FX)
+ 6%
(+7% excluding FX)
+ 14%
(+16% excluding FX)
Sales
9
Q3 2024 RESULTS – ORGANIC REVENUE
GROWTH BY REGION VS PY
9
+9%
+5%
+11%
+27%
Avient ex.
https://www.avient.com/sites/default/files/2025-04/CCG PVDF Monofilament Case Study Snapshot.pdf
MONOFIL AMENT
MA NUFAC TURER
P V D F F I L A M E N T E X T R U S I O N
• Reduce or eradicate die build-up
• Improve predictive and final part quality
• Optimize PVDF extrusion for the desired coefficient of
friction (CoF)
• Reduce energy consumption
• Boosted overall production efficiency by
minimizing die build-up through use of a
PVDF-specific processing aid
• Achieved a flawless surface by reducing
friction and improving flow for enhanced
final part quality
• Controlled extrusion pressure to reduce
energy required in processing
Colorant Chromatics PVDF Processing Aid
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2025-04/CCG PVDF Extrusion_Molding Case Study.pdf
WIR E & CABLE OEM
P V D F E X T R U S I O N
• Improve extrusion line speed
• Minimize defects, optimize coefficient of friction (CoF), control
extrusion pressure, and eliminate die drool
• Prevent melt fracture (sharkskin)
• Reduce energy use in processing to achieve cost savings
• Delivered a polyvinylidene fluoride (PVDF)
solution that improved extrusion production times
• Provided application specialists with deep
knowledge of PVDF processing windows (melt
and degradation temperatures) to help boost
overall processing performance
• Enhanced surface aesthetics by reducing friction
and improving flow stability
• Gained a reduction in energy use and offered
added savings for other PVDF applications such
as wire jacketing or tube and pipe extrusion
Colorant Chromatics PVDF Processing Aid
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/resources/Polyone%2520Barbastro_ISO%252014001_2015_EXP%25202021_0.pdf
Industrial Valle del Cinca
s/n Apartado 18
22300 Barbastro, Huesca
Spain
has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by:
ISO 14001:2015
The Environment Management System is applicable to:
DEVELOPMENT, PRODUCTION & DISTRIBUTION OF TECHNICAL THERMOPLASTICS.
https://www.avient.com/sites/default/files/resources/Polyone%2520Barbastro_ISO%25209001_2015%2520EXP%25202021.pdf
Industrial Valle del Cinca
s/n Apartado 18
22300 Barbastro, Huesca
Spain
has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by:
ISO 9001:2015
The Quality Management System is applicable to:
DEVELOPMENT, PRODUCTION & DISTRIBUTION OF TECHNICAL THERMOPLASTICS.
https://www.avient.com/sites/default/files/2020-12/case-study-one-pager-maxxam-fr-fridge-base.pdf
GLOBAL FRIDGE
MANUFACTURER
R E F R I G E R A T O R B A S E
• Provide 5VA flame retardant rating
• Utilize existing molds
• Keep the same mechanical and physical properties as current
material
• Dimensional stability – limit shrinkage of final part
• High strength – bearing the weight of the whole fridge
• Maintain or reduce weight
• Expedited development time, providing solutions
ready for testing within a week
• Enabled first time approval through close
customer collaboration
• Provided excellent in person support to both
customer and moulder throughout trials
• Gave technical advice on how to adjust
processing parameters, enabling the use of
existing molds with the new material
Maxxam™ FR Flame Retardant Formulations
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2021-04/trilliant-hc8900-medical-device-housing-case-study.pdf
DEVICE
MANUFACTURER
M E D I C A L D E V I C E H O U S I N G
• Improved chemical resistance compared to PC/ABS,
PC/PET & COPE
• Flame retardant (FR) rating of V-1 at 0.75 mm
• Zero BPA & non-halogenated FR material
• Available in standard hospital grade pre-colors
• Provided a cost-effective material with superior
chemical resistance to traditional materials
• Formulated a medical-grade, semi-crystalline
blend to support regulatory testing and
approvals
• Demonstrated superior property retention and
crack resistance after exposure to hospital-
grade disinfectants, including Virex® Tb,
helping to extend the device life
Trilliant™ HC8900 Thermoplastics
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2020-09/case-study-one-pager-hybrid-5g-cable.pdf
OFC
MANUFACTURER
5 G H Y B R I D C A B L E
J A C K E T I N G & I N S U L A T I O N
• Fire performance: reduce smoke and fume production,
high flame and char resistance
• Reduce development time
• Meet required standards: UL 1581 (Class XL) mechanical
properties , UL 1685 (flame test/smoke parameters), FT2
& FV2 (VW1)
• Accelerated speed to market, reducing
development time to three months
• Instilled confidence and proved material
expertise as solutions passed extensive
testing ahead of competition
• Optimized cable manufacture process and
line speed following trials at customers
facility
ECCOH 5549/1 LDD & Syncure™ S100FH
KEY REQUIREMENTS
WHY AVIENT?